$8.09
-0.28-3.35%
After Hours: 1:00 PM EDT
15 minutes delayed
Replimune Group
REPLNASDAQ
Replimune Group (NASDAQ:REPL) Stock, Analyst Ratings, Price Targets, Predictions
Replimune Group Inc has a consensus price target of $41.55, established from looking at the 32 latest analyst ratings. The last 3 analyst ratings were released from Barclays, HC Wainwright & Co., and Barclays on June 7, 2024, June 7, 2024, and December 6, 2023. With an average price target of $15.67 between Barclays, HC Wainwright & Co., and Barclays, there's an implied 93.65% upside for Replimune Group Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Barclays
HC Wainwright & Co.
Wedbush
JP Morgan
EF Hutton
1calculated from analyst ratings
Analyst Ratings for Replimune Group
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/07/2024 | Buy Now | 110.14% | Barclays | Peter Lawson | $13 → $17 | Maintains | Overweight | Get Alert |
| 06/07/2024 | Buy Now | 110.14% | HC Wainwright & Co. | Robert Burns | $12 → $17 | Maintains | Buy | Get Alert |
| 12/06/2023 | Buy Now | 60.69% | Barclays | Peter Lawson | $50 → $13 | Maintains | Overweight | Get Alert |
| 11/13/2023 | Buy Now | 493.33% | HC Wainwright & Co. | Robert Burns | $50 → $48 | Maintains | Buy | Get Alert |
| 11/08/2023 | Buy Now | 542.77% | Wedbush | Robert Driscoll | → $52 | Reiterates | Outperform → Outperform | Get Alert |
| 08/07/2023 | Buy Now | 518.05% | HC Wainwright & Co. | Robert Burns | $51 → $50 | Maintains | Buy | Get Alert |
| 08/01/2023 | Buy Now | 530.41% | HC Wainwright & Co. | Robert Burns | → $51 | Reiterates | Buy → Buy | Get Alert |
| 06/15/2023 | Buy Now | 518.05% | JP Morgan | Anupam Rama | $38 → $50 | Maintains | Overweight | Get Alert |
| 06/08/2023 | Buy Now | 530.41% | HC Wainwright & Co. | Robert Burns | → $51 | Reiterates | Buy → Buy | Get Alert |
| 06/07/2023 | Buy Now | 542.77% | Wedbush | Robert Driscoll | → $52 | Reiterates | Outperform → Outperform | Get Alert |
| 06/07/2023 | Buy Now | 641.66% | EF Hutton | Tony Butler | → $60 | Reiterates | Buy → Buy | Get Alert |
| 06/05/2023 | Buy Now | 530.41% | HC Wainwright & Co. | Robert Burns | $50 → $51 | Maintains | Buy | Get Alert |
| 06/05/2023 | Buy Now | 641.66% | EF Hutton | Tony Butler | → $60 | Reiterates | Buy → Buy | Get Alert |
| 05/26/2023 | Buy Now | 641.66% | EF Hutton | Tony Butler | → $60 | Reiterates | Buy → Buy | Get Alert |
| 05/22/2023 | Buy Now | 542.77% | Wedbush | Robert Driscoll | → $52 | Reiterates | Outperform → Outperform | Get Alert |
| 04/17/2023 | Buy Now | 443.88% | Piper Sandler | Allison Bratzel | → $44 | Assumes | → Overweight | Get Alert |
| 02/10/2023 | Buy Now | 518.05% | HC Wainwright & Co. | Robert Burns | $48 → $50 | Reiterates | → Buy | Get Alert |
| 01/05/2023 | Buy Now | 641.66% | EF Hutton | Tony Butler | → $60 | Initiates | → Buy | Get Alert |
| 12/12/2022 | Buy Now | 765.27% | BMO Capital | Evan David Seigerman | $40 → $70 | Maintains | Outperform | Get Alert |
| 12/07/2022 | Buy Now | 320.27% | SVB Leerink | Jonathan Chang | $30 → $34 | Maintains | Outperform | Get Alert |
| 11/04/2022 | Buy Now | 493.33% | HC Wainwright & Co. | Robert Burns | $60 → $48 | Maintains | Buy | Get Alert |
| 10/14/2022 | Buy Now | 394.44% | BMO Capital | Evan Seigerman | $30 → $40 | Maintains | Outperform | Get Alert |
| 10/03/2022 | Buy Now | 270.83% | SVB Leerink | Jonathan Chang | $37 → $30 | Maintains | Outperform | Get Alert |
| 08/16/2022 | Buy Now | 431.52% | Piper Sandler | Do Kim | $44 → $43 | Maintains | Overweight | Get Alert |
| 08/05/2022 | Buy Now | 357.35% | SVB Leerink | Jonathan Chang | $48 → $37 | Maintains | Outperform | Get Alert |
| 05/24/2022 | Buy Now | 542.77% | Wedbush | Robert Driscoll | $59 → $52 | Maintains | Outperform | Get Alert |
| 05/20/2022 | Buy Now | 493.33% | SVB Leerink | Jonathan Chang | $49 → $48 | Maintains | Outperform | Get Alert |
| 04/04/2022 | Buy Now | 382.08% | JP Morgan | Anupam Rama | $47 → $39 | Maintains | Overweight | Get Alert |
| 03/18/2022 | Buy Now | 270.83% | BMO Capital | Matthew Luchini | $51 → $30 | Maintains | Outperform | Get Alert |
| 11/19/2021 | Buy Now | 542.77% | Piper Sandler | Do Kim | — | Initiates | → Overweight | Get Alert |
| 08/23/2021 | Buy Now | 505.69% | SVB Leerink | Jonathan Chang | — | Maintains | Outperform | Get Alert |
| 08/09/2021 | Buy Now | 579.85% | SVB Leerink | Jonathan Chang | — | Maintains | Outperform | Get Alert |
FAQ
What is the target price for Replimune Group (REPL) stock?
The latest price target for Replimune Group (NASDAQ:REPL) was reported by Barclays on June 7, 2024. The analyst firm set a price target for $17.00 expecting REPL to rise to within 12 months (a possible 110.14% upside). 7 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Replimune Group (REPL)?
The latest analyst rating for Replimune Group (NASDAQ:REPL) was provided by Barclays, and Replimune Group maintained their overweight rating.
When was the last upgrade for Replimune Group (REPL)?
There is no last upgrade for Replimune Group
When was the last downgrade for Replimune Group (REPL)?
There is no last downgrade for Replimune Group.
When is the next analyst rating going to be posted or updated for Replimune Group (REPL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Replimune Group, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Replimune Group was filed on June 7, 2024 so you should expect the next rating to be made available sometime around June 7, 2025.
Is the Analyst Rating Replimune Group (REPL) correct?
While ratings are subjective and will change, the latest Replimune Group (REPL) rating was a maintained with a price target of $13.00 to $17.00. The current price Replimune Group (REPL) is trading at is $8.09, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.